VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN: 2,002 Adverse Event Reports & Safety Profile
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
2,002
Total FAERS Reports
79 (3.9%)
Deaths Reported
265
Hospitalizations
2,002
As Primary/Secondary Suspect
30
Life-Threatening
57
Disabilities
Merck Sharp & Dohme LLC
Manufacturer
Drug Class: Actively Acquired Immunity [PE] · Manufacturer: Merck Sharp & Dohme LLC ·
First Report: 1990 · Latest Report: 20250925
What Are the Most Common VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN Side Effects?
#1 Most Reported
No adverse event
772 reports (38.6%)
#2 Most Reported
Product storage error
330 reports (16.5%)
#3 Most Reported
Drug ineffective
245 reports (12.2%)
All VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| No adverse event | 772 | 38.6% | 0 | 0 |
| Product storage error | 330 | 16.5% | 1 | 0 |
| Drug ineffective | 245 | 12.2% | 4 | 45 |
| Herpes zoster | 209 | 10.4% | 9 | 39 |
| Diarrhoea | 135 | 6.7% | 2 | 37 |
| Nausea | 133 | 6.6% | 0 | 27 |
| Drug intolerance | 125 | 6.2% | 0 | 17 |
| Expired product administered | 125 | 6.2% | 0 | 2 |
| Pruritus | 119 | 5.9% | 0 | 22 |
| Pyrexia | 119 | 5.9% | 11 | 37 |
| Hypersensitivity | 109 | 5.4% | 0 | 23 |
| Pain | 105 | 5.2% | 16 | 37 |
| Vaccination failure | 102 | 5.1% | 10 | 26 |
| Lymphoma | 101 | 5.0% | 0 | 1 |
| Off label use | 99 | 5.0% | 2 | 39 |
| Alopecia | 97 | 4.9% | 0 | 3 |
| Neoplasm malignant | 97 | 4.9% | 0 | 1 |
| Rash | 97 | 4.9% | 3 | 41 |
| Tooth loss | 96 | 4.8% | 0 | 2 |
| Onychoclasis | 94 | 4.7% | 0 | 1 |
Who Reports VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN Side Effects? Age & Gender Data
Gender: 54.9% female, 45.1% male. Average age: 39.7 years. Most reports from: US. View detailed demographics →
Is VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 1 | 0 | 0 |
| 2002 | 1 | 0 | 0 |
| 2004 | 1 | 0 | 0 |
| 2005 | 3 | 0 | 1 |
| 2006 | 2 | 0 | 0 |
| 2007 | 2 | 0 | 0 |
| 2008 | 1 | 0 | 1 |
| 2009 | 8 | 2 | 2 |
| 2010 | 5 | 3 | 3 |
| 2011 | 7 | 1 | 3 |
| 2012 | 13 | 0 | 4 |
| 2013 | 22 | 1 | 11 |
| 2014 | 44 | 3 | 13 |
| 2015 | 74 | 4 | 14 |
| 2016 | 86 | 12 | 15 |
| 2017 | 381 | 16 | 24 |
| 2018 | 129 | 2 | 20 |
| 2019 | 161 | 1 | 6 |
| 2020 | 45 | 1 | 3 |
| 2021 | 44 | 0 | 16 |
| 2022 | 53 | 2 | 2 |
| 2023 | 48 | 0 | 11 |
| 2024 | 44 | 2 | 6 |
| 2025 | 123 | 0 | 10 |
What Is VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN Used For?
| Indication | Reports |
|---|---|
| Prophylaxis | 1,444 |
| Product used for unknown indication | 270 |
| Immunisation | 123 |
| Routine health maintenance | 49 |
| Rheumatoid arthritis | 38 |
| Varicella immunisation | 34 |
| Herpes zoster | 26 |
| Herpes zoster immunisation | 5 |
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN vs Alternatives: Which Is Safer?
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN vs VASOPRESSIN
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN vs VECTIBIX
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN vs VECURONIUM
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN vs VEDOLIZUMAB
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN vs VELAGLUCERASE ALFA
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN vs VELCADE
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN vs VELETRI
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN vs VELIPARIB
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN vs VEMURAFENIB
VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN vs VENETOCLAX
Other Drugs in Same Class: Actively Acquired Immunity [PE]
BACILLUS CALMETTE-GUERIN SUBSTRAIN TICE LIVE ANTIGEN (1,937)
YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN (79)
HUMAN ROTAVIRUS A TYPE G1P STRAIN RIX4414 LIVE ANTIGEN (56)
HEPATITIS A VIRUS STRAIN 326F ANTIGEN (46)
HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (45)
HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN (27)
HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN (24)
SALMONELLA TYPHI TY2 VI POLYSACCHARIDE ANTIGEN (20)
View all →
Class side effects →
Compare in class →
Official FDA Label for VARICELLA-ZOSTER VIRUS STRAIN OKA/MERCK LIVE ANTIGEN
Official prescribing information from the FDA-approved drug label.